TRINITY BIOTECH IN VITRO DIJAGNOSTIKA クロアチア - クロアチア語 - HALMED (Agencija za lijekove i medicinske proizvode)

trinity biotech in vitro dijagnostika

jasika d.o.o., zagreb - reagensi, kontrole i pomoćni materijali za in vitro dijagnostiku zaraznih bolesti

DIPHERELINE 0.1mg/1ml Prašak i rastvarač za rastvor za injekciju モンテネグロ - クロアチア語 - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

diphereline 0.1mg/1ml prašak i rastvarač za rastvor za injekciju

pharmaswiss - montenegro, pharmaswiss doo beograd, dio stranog druŠtva u podgorici - triptorelin - prašak i rastvarač za rastvor za injekciju - 0.1mg/1ml

Spikevax (previously COVID-19 Vaccine Moderna) 欧州連合 - クロアチア語 - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Cevenfacta 欧州連合 - クロアチア語 - EMA (European Medicines Agency)

cevenfacta

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorrhagics - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.

HUMIRA 40mg/0.8ml Rastvor za injekciju u napunjenom injekcionom špricu モンテネグロ - クロアチア語 - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

humira 40mg/0.8ml rastvor za injekciju u napunjenom injekcionom špricu

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - adalimumab - rastvor za injekciju u napunjenom injekcionom špricu - 40mg/0.8ml